ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inactivated Polio Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19G10048
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Inactivated Polio Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Inactivated Polio Vaccine Market Research Report 2025

Code: QYRE-Auto-19G10048
Report
July 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals

Inactivated Polio Vaccine Market Size

The global market for Inactivated Polio Vaccine was valued at US$ 744 million in the year 2024 and is projected to reach a revised size of US$ 1002 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Inactivated Polio Vaccine Market

Inactivated Polio Vaccine Market

Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inactivated Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Polio Vaccine.
The Inactivated Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Polio Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Inactivated Polio Vaccine Market Report

Report Metric Details
Report Name Inactivated Polio Vaccine Market
Accounted market size in year US$ 744 million
Forecasted market size in 2031 US$ 1002 million
CAGR 4.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Government
  • Private Sector
Segment by Application
  • Pediatrics
  • Adults
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Inactivated Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Inactivated Polio Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Inactivated Polio Vaccine Market growing?

Ans: The Inactivated Polio Vaccine Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Inactivated Polio Vaccine Market size in 2031?

Ans: The Inactivated Polio Vaccine Market size in 2031 will be US$ 1002 million.

Who are the main players in the Inactivated Polio Vaccine Market report?

Ans: The main players in the Inactivated Polio Vaccine Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Inactivated Polio Vaccine Market report?

Ans: The Applications covered in the Inactivated Polio Vaccine Market report are Pediatrics, Adults

What are the Type segmentation covered in the Inactivated Polio Vaccine Market report?

Ans: The Types covered in the Inactivated Polio Vaccine Market report are Government, Private Sector

Recommended Reports

Human Vaccine Markets

Adjuvants & Technologies

Pediatric & Specialty Vaccines

1 Inactivated Polio Vaccine Market Overview
1.1 Product Definition
1.2 Inactivated Polio Vaccine by Type
1.2.1 Global Inactivated Polio Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Government
1.2.3 Private Sector
1.3 Inactivated Polio Vaccine by Application
1.3.1 Global Inactivated Polio Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Inactivated Polio Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Polio Vaccine Revenue 2020-2031
1.4.2 Global Inactivated Polio Vaccine Sales 2020-2031
1.4.3 Global Inactivated Polio Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Polio Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Polio Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Polio Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Polio Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Polio Vaccine, Date of Enter into This Industry
2.8 Global Inactivated Polio Vaccine Market Competitive Situation and Trends
2.8.1 Global Inactivated Polio Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Polio Vaccine Players Market Share by Revenue
2.8.3 Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Polio Vaccine Market Scenario by Region
3.1 Global Inactivated Polio Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Polio Vaccine Sales by Region: 2020-2031
3.2.1 Global Inactivated Polio Vaccine Sales by Region: 2020-2025
3.2.2 Global Inactivated Polio Vaccine Sales by Region: 2026-2031
3.3 Global Inactivated Polio Vaccine Revenue by Region: 2020-2031
3.3.1 Global Inactivated Polio Vaccine Revenue by Region: 2020-2025
3.3.2 Global Inactivated Polio Vaccine Revenue by Region: 2026-2031
3.4 North America Inactivated Polio Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Polio Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Polio Vaccine Sales by Country (2020-2031)
3.4.3 North America Inactivated Polio Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inactivated Polio Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Polio Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Polio Vaccine Sales by Country (2020-2031)
3.5.3 Europe Inactivated Polio Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Polio Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Polio Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Polio Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Polio Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inactivated Polio Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Polio Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Polio Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Polio Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Polio Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Polio Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Polio Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inactivated Polio Vaccine Sales by Type (2020-2031)
4.1.1 Global Inactivated Polio Vaccine Sales by Type (2020-2025)
4.1.2 Global Inactivated Polio Vaccine Sales by Type (2026-2031)
4.1.3 Global Inactivated Polio Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Polio Vaccine Revenue by Type (2020-2031)
4.2.1 Global Inactivated Polio Vaccine Revenue by Type (2020-2025)
4.2.2 Global Inactivated Polio Vaccine Revenue by Type (2026-2031)
4.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Polio Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Polio Vaccine Sales by Application (2020-2031)
5.1.1 Global Inactivated Polio Vaccine Sales by Application (2020-2025)
5.1.2 Global Inactivated Polio Vaccine Sales by Application (2026-2031)
5.1.3 Global Inactivated Polio Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Polio Vaccine Revenue by Application (2020-2031)
5.2.1 Global Inactivated Polio Vaccine Revenue by Application (2020-2025)
5.2.2 Global Inactivated Polio Vaccine Revenue by Application (2026-2031)
5.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Polio Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Inactivated Polio Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Inactivated Polio Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bibcol
6.3.1 Bibcol Company Information
6.3.2 Bibcol Description and Business Overview
6.3.3 Bibcol Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bibcol Inactivated Polio Vaccine Product Portfolio
6.3.5 Bibcol Recent Developments/Updates
6.4 Serum Institute
6.4.1 Serum Institute Company Information
6.4.2 Serum Institute Description and Business Overview
6.4.3 Serum Institute Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Serum Institute Inactivated Polio Vaccine Product Portfolio
6.4.5 Serum Institute Recent Developments/Updates
6.5 Tiantan Biological
6.5.1 Tiantan Biological Company Information
6.5.2 Tiantan Biological Description and Business Overview
6.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Tiantan Biological Inactivated Polio Vaccine Product Portfolio
6.5.5 Tiantan Biological Recent Developments/Updates
6.6 Panacea Biotec
6.6.1 Panacea Biotec Company Information
6.6.2 Panacea Biotec Description and Business Overview
6.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Panacea Biotec Inactivated Polio Vaccine Product Portfolio
6.6.5 Panacea Biotec Recent Developments/Updates
6.7 Bio-Med
6.7.1 Bio-Med Company Information
6.7.2 Bio-Med Description and Business Overview
6.7.3 Bio-Med Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Med Inactivated Polio Vaccine Product Portfolio
6.7.5 Bio-Med Recent Developments/Updates
6.8 Halfkin Bio-Pharmaceuticals
6.8.1 Halfkin Bio-Pharmaceuticals Company Information
6.8.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
6.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Portfolio
6.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Polio Vaccine Industry Chain Analysis
7.2 Inactivated Polio Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Polio Vaccine Production Mode & Process Analysis
7.4 Inactivated Polio Vaccine Sales and Marketing
7.4.1 Inactivated Polio Vaccine Sales Channels
7.4.2 Inactivated Polio Vaccine Distributors
7.5 Inactivated Polio Vaccine Customer Analysis
8 Inactivated Polio Vaccine Market Dynamics
8.1 Inactivated Polio Vaccine Industry Trends
8.2 Inactivated Polio Vaccine Market Drivers
8.3 Inactivated Polio Vaccine Market Challenges
8.4 Inactivated Polio Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
GSK
Bibcol
Serum Institute
Tiantan biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals
List of Tables
 Table 1. Global Inactivated Polio Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Inactivated Polio Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Inactivated Polio Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Inactivated Polio Vaccine Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Inactivated Polio Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Inactivated Polio Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Inactivated Polio Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Inactivated Polio Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Inactivated Polio Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Inactivated Polio Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Inactivated Polio Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inactivated Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inactivated Polio Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Inactivated Polio Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Inactivated Polio Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Inactivated Polio Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Inactivated Polio Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Inactivated Polio Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Inactivated Polio Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Inactivated Polio Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Inactivated Polio Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Inactivated Polio Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Inactivated Polio Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Inactivated Polio Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Inactivated Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Inactivated Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Inactivated Polio Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Inactivated Polio Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Inactivated Polio Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Inactivated Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Inactivated Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Inactivated Polio Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Inactivated Polio Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Inactivated Polio Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Inactivated Polio Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Inactivated Polio Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Inactivated Polio Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Inactivated Polio Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Inactivated Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Inactivated Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Inactivated Polio Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Inactivated Polio Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Inactivated Polio Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Inactivated Polio Vaccine Sales (K Dose) by Type (2020-2025)
 Table 51. Global Inactivated Polio Vaccine Sales (K Dose) by Type (2026-2031)
 Table 52. Global Inactivated Polio Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Inactivated Polio Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Inactivated Polio Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Inactivated Polio Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Inactivated Polio Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Inactivated Polio Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Inactivated Polio Vaccine Sales (K Dose) by Application (2020-2025)
 Table 61. Global Inactivated Polio Vaccine Sales (K Dose) by Application (2026-2031)
 Table 62. Global Inactivated Polio Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Inactivated Polio Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Inactivated Polio Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Inactivated Polio Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Inactivated Polio Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Inactivated Polio Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Sanofi Inactivated Polio Vaccine Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. GSK Inactivated Polio Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Bibcol Company Information
 Table 81. Bibcol Description and Business Overview
 Table 82. Bibcol Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Bibcol Inactivated Polio Vaccine Product
 Table 84. Bibcol Recent Developments/Updates
 Table 85. Serum Institute Company Information
 Table 86. Serum Institute Description and Business Overview
 Table 87. Serum Institute Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Serum Institute Inactivated Polio Vaccine Product
 Table 89. Serum Institute Recent Developments/Updates
 Table 90. Tiantan Biological Company Information
 Table 91. Tiantan Biological Description and Business Overview
 Table 92. Tiantan Biological Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Tiantan Biological Inactivated Polio Vaccine Product
 Table 94. Tiantan Biological Recent Developments/Updates
 Table 95. Panacea Biotec Company Information
 Table 96. Panacea Biotec Description and Business Overview
 Table 97. Panacea Biotec Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Panacea Biotec Inactivated Polio Vaccine Product
 Table 99. Panacea Biotec Recent Developments/Updates
 Table 100. Bio-Med Company Information
 Table 101. Bio-Med Description and Business Overview
 Table 102. Bio-Med Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Bio-Med Inactivated Polio Vaccine Product
 Table 104. Bio-Med Recent Developments/Updates
 Table 105. Halfkin Bio-Pharmaceuticals Company Information
 Table 106. Halfkin Bio-Pharmaceuticals Description and Business Overview
 Table 107. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product
 Table 109. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Inactivated Polio Vaccine Distributors List
 Table 113. Inactivated Polio Vaccine Customers List
 Table 114. Inactivated Polio Vaccine Market Trends
 Table 115. Inactivated Polio Vaccine Market Drivers
 Table 116. Inactivated Polio Vaccine Market Challenges
 Table 117. Inactivated Polio Vaccine Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inactivated Polio Vaccine
 Figure 2. Global Inactivated Polio Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Inactivated Polio Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Government Product Picture
 Figure 5. Private Sector Product Picture
 Figure 6. Global Inactivated Polio Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Inactivated Polio Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Pediatrics
 Figure 9. Adults
 Figure 10. Global Inactivated Polio Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Inactivated Polio Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Inactivated Polio Vaccine Sales (2020-2031) & (K Dose)
 Figure 13. Global Inactivated Polio Vaccine Average Price (US$/Dose) & (2020-2031)
 Figure 14. Inactivated Polio Vaccine Report Years Considered
 Figure 15. Inactivated Polio Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Inactivated Polio Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Inactivated Polio Vaccine Players: Market Share by Revenue in Inactivated Polio Vaccine in 2024
 Figure 18. Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Inactivated Polio Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Inactivated Polio Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Inactivated Polio Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Inactivated Polio Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Inactivated Polio Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Inactivated Polio Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Inactivated Polio Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Inactivated Polio Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Inactivated Polio Vaccine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Inactivated Polio Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Inactivated Polio Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Inactivated Polio Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Inactivated Polio Vaccine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Inactivated Polio Vaccine by Type (2020-2031)
 Figure 54. Global Inactivated Polio Vaccine Price (US$/Dose) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Inactivated Polio Vaccine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Inactivated Polio Vaccine by Application (2020-2031)
 Figure 57. Global Inactivated Polio Vaccine Price (US$/Dose) by Application (2020-2031)
 Figure 58. Inactivated Polio Vaccine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Inactivated Polio and Rabies Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Poliovirus Vaccine Inactivated Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polio Vaccination Market Research Report 2025
Global Poliomyelitis Vaccine Market Research Report 2025
Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Combined Polio Vaccine Market Research Report 2024
Global Poliomycetes Vaccine Market Insights Forecast to 2030
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Vaccine Market
Swine Hyopneumoniae Mycoplasma Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Polio Vaccines OPV Market Research Report 2024
Global Inactivated Polio Virus Vaccine Market Research Report 2025
Global Influenza Vaccine Split Virion Inactivated Quadrivalent Market Research Report 2024
Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2025
Inactivated Vaccine for Swine Mycoplasma Pneumonia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Polio Vaccine Market Research Report 2024
Global Inactivated Poultry Vaccine Market Research Report 2025
Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poliomyelitis Vaccine in Dragee Candy Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions